Alcon Sues To Block Mylan's Bid For Generic Glaucoma Drug

Law360, New York (July 26, 2013, 8:44 PM EDT) -- Alcon Research Ltd. is trying to halt Mylan Inc.'s plans to debut a generic form of the glaucoma treatment Travatan Z, accusing Mylan in a suit filed in Delaware federal court Friday of seeking government approval for a drug that would infringe three Alcon patents.

The complaint says Mylan has attempted to get the U.S. Food and Drug Administration to sign off on its abbreviated new drug application for eye drops containing the active ingredient travoprost — a product almost identical to Travatan Z — before...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.